Form 4: ProMIS Neurosciences Insider Buys Shares

Michael S. Gordon, a director of ProMIS Neurosciences Inc., recently purchased shares of the company's common stock in multiple transactions.

Summary

• On September 16, 2024, Michael S. Gordon purchased 76,931 common shares at a weighted average price of $1.2228.
• The prices for these shares ranged from $1.1200 to $1.3700.
• On September 17, 2024, he purchased an additional 16,292 common shares at a weighted average price of $1.40, with prices ranging from $1.37 to $1.40.
• Following these transactions, Gordon directly owns 93,223 common shares.
• He also indirectly owns 2,075,629 shares through Title 19 Promis and 48,333 shares through Title 19 Acies, both Delaware limited liability companies where he is the sole manager.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying is generally viewed favorably, but the scale of the purchase needs to be considered in relation to the individual's holdings and the company's overall market capitalization.

Positives

• A director's purchase of shares can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider buying is often monitored by investors as an indicator of management's sentiment regarding the company's prospects. It can be compared to other insider transactions within the biotechnology sector to gauge overall confidence levels.

Comparison to Industry Standards

• Comparing the size and frequency of these insider buys to those of executives at similar-stage biotech companies (e.g., those focused on neurodegenerative diseases) could provide context.
• For example, if executives at companies like AC Immune SA or Biogen Inc. have recently made similar purchases, it could indicate a broader positive sentiment in the sector.
• Conversely, a lack of insider buying at comparable firms might make this purchase more noteworthy.

Stakeholder Impact

• Shareholders may view the insider purchase as a positive signal.
• Employees might see it as a sign of confidence in the company's direction.

Key Dates